Using Age- and Sex-Specific Risk Thresholds to Guide Statin Therapy
| Autor: | Michael J. Pencina, Ralph B. D'Agostino, Allan D. Sniderman, Ann Marie Navar-Boggan, Eric D. Peterson |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Framingham Risk Score Statin business.industry medicine.drug_class Cholesterol Offspring Specific risk Disease 030204 cardiovascular system & hematology Age and sex 3. Good health 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Internal medicine Physical therapy medicine cardiovascular diseases 030212 general & internal medicine Statin therapy Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of the American College of Cardiology. 65:1633-1639 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/j.jacc.2015.02.025 |
| Popis: | Background New cholesterol guidelines emphasize 10-year risk of cardiovascular disease (CVD) to identify adults eligible for statin therapy as primary prevention. Whether these CVD risk thresholds should be individualized by age and sex has not been explored. Objectives This study evaluated the potential impact of incorporating age- and sex-specific CVD risk thresholds into current cholesterol guidelines. Methods Using data from the Framingham Offspring Study, this study assessed current treatment recommendations among age- and sex-specific groups in 3,685 participants free of CVD. Then, it evaluated how varying age- and sex-specific 10-year CVD risk thresholds for statin treatment affect the sensitivity and specificity for incident 10-year CVD events. Results Basing statin therapy recommendations on a 10-year fixed risk threshold of 7.5% results in lower statin consideration among women than men (63% vs. 33%; p Conclusions Cholesterol treatment recommendations could be improved by using individualized age- and sex-specific CVD risk thresholds. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|